The Focal Therapy Clinic was established by three world-renowned practitioners of focal therapy – Tim Dudderidge, Marc Laniado and Raj Nigam, and they have been recently joined by the equally eminent, Alan Doherty. Alongside other industry experts and treatment providers such as Sonacare and NMS they have created The Focal Therapy Clinic to provide confidential help and advice to patients who should be considering focal therapy as part of their treatment options.
The Focal Therapy Clinic are about choice. Your choice in how your prostate cancer is treated. Because radical treatment can impact your urinary and sexual function for the rest of your life, while Active Surveillance may leave you feeling obligated to long-term patient status, our objective is for you to understand all your treatment options and how they may impact your life.
We offer men with low- to intermediate- risk prostate cancer access to focal therapy, and to the clinical innovators and pioneers of this ground-breaking treatment.
We believe that focal therapy is a powerful alternative to both surgery and Active Surveillance — offering effective cancer control while preserving sexual and urinary function in patients. These are often seen as a trade-off, and we have developed and supported an approach to managing prostate cancer that preserves patients overall quality of life.
We were formed by a group of clinicians and clinical service providers who have been at the forefront of advancing focal therapy in the UK for over ten years. Our clinicians have practised focal therapy with great success on hundreds of patients and are major contributors to clinical trials demonstrating its effectiveness.
Our service providers have brought the technology and expertise into hospitals and clinics allowing clinicians to offer focal therapy to their patients. They have been significant innovators in developing technology around precision diagnostics and nuanced treatments for prostate cancer, and have worked for over ten years with the NHS, private hospital groups BMI, Nuffield and Spire and insurers AXA/PPP, BUPA and Aviva to ensure that focal therapy is understood and made available as a treatment option to their patients.
As a group of consultants we are passionate about all prostate cancer sufferers knowing about all of their treatment options.
Based upon the details that you know and can provide to us, we will send you a Plain English personalised preliminary suitability report for HIFU Focal Therapy treatment of your prostate cancer.
You can use the information we provide in your conversations with your existing NHS and/or private treatment consultant. Should you wish to talk with us further we would be grateful to help you, but there is absolutely no obligation for you to do so whatsoever.